Abstract:Abstract BACKGROUND Pediatric brain tumors (PBTs) pose a significant challenge being the leading cause of cancer related mortality in children. The existing classification process is time-consuming and fails to capture the heterogeneity of PBTs. Urgent advancements in diagnostic and therapeutic approaches are needed. The WHO classification 5th edition for CNS tumors introduced DNA methylation analysis into the diagnostic process, especially for difficult-to-diagnose cases. However, the currently available DNA methylation array-based methods are laborious, costly, &require large amounts of DNA METHODS Nanopore methylation analysis is rapid, accurate, and inexpensive & requires minimal tissue. We applied this technology on 24 PBT samples that were classified into ten molecular subgroups. RESULTS Our results were compatible with those obtained through Heidelberg methylation analysis, standard histopathological examination, and molecular tests and were in concordance with the final neuro-pathological diagnosis. Moreover, for five prospective cases, that would have challenged standard methods, Nanopore yielded same-day results, guiding additional tests and providing a significant diagnostic advantage. In one case, a 2.2-year-old male, with a large left parieto-temporal tumor and a suprasellar lesioninitially treated elsewhere with upfront chemotherapy without biopsy, developed clinical deterioration. We resected the temporal lesion and frozen tissue diagnosis suggested low-grade glioma. However, same day Nanopore sequencing analysis indicated a high score for ‘Meningioma’. Final pathology examination 10 days later confirmed ‘‘Atypical meningioma, WHO grade 2” – an extremely rare diagnosis in this age group. Visual deterioration prompted immediate resection of the second lesion before final pathological confirmation. Thus, early Nanopore classification played a vital role in diagnosis and management. CONCLUSIONS Our preliminary results underscore the potential of Nanopore potential for accurate and rapid PBT classification from small brain biopsies, with DNA input as low as 100 nanograms. This cutting-edge technology promises to substantially reduce time to diagnosis, shaping future neurosurgical strategies for individualized PBT patient management.

Epco-16. Method To Model And Correct Noise In Single-Nuclei Rna-Sequencing Data From Post-Mortem Brain

Characterizing cell type specific transcriptional differences between the living and postmortem human brain

Single Nucleus Total RNA Sequencing of Formalin-Fixed Paraffin-Embedded Gliomas.

Gene expression profiles derived from single cells in human postmortem brain.

An automated archival single-nucleus total RNA sequencing platform mapping integrative and retrospective cell atlas of gliomas

Epco-11. Biases In Healthy Brain Single-Cell Datasets: Finding The Best Comparison For Glioblastoma Studies

162. LCM-RRBS: A Novel PCR-Amplicon Based Method Compatible with Post-Mortem Samples

Exploration of the R Code-Based Mathematical Model for Pmi Estimation Using Profiling of Rna Degradation in Rat Brain Tissue at Different Temperatures

Probing Glioblastoma and Its Microenvironment Using Single-Nucleus and Single-Cell Sequencing.

Highly Multiplexed Spatially Resolved Proteomic and Transcriptional Profiling of the Glioblastoma Microenvironment Using Archived Formalin-Fixed Paraffin-Embedded Specimens

Dissection of artifactual and confounding glial signatures by single-cell sequencing of mouse and human brain

Agonal Factors Distort Gene-Expression Patterns in Human Postmortem Brains

Practical Guidelines for High-Resolution Epigenomic Profiling of Nucleosomal Histones in Postmortem Human Brain Tissue

Epco-40. Transcriptional Trajectory Inference Of Image-Localized, Multi-Regional High-Grade Glioma Biopsies Reveals Distinct Population Ecologies And Sex-Associated Enriched Pathways

Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues

Epco-03. Metabolic Insight Into Glioma Heterogeneity: Mapping Whole Exome Sequencing Toin Vivo Imaging With Stereotactic Localization And Deep Learning

A novel necroptosis-related gene signature for predict prognosis of glioma based on single-cell and bulk RNA sequencing

An experimental study to estimate the early postmortem interval based on the degradation of lncRNAs in rat brain tissue

Joint Modeling of RNAseq and Radiomics Data for Glioma Molecular Characterization and Prediction

Towards accesible brain-tumor classification at the point of care: Nanopore methylation sequencing from Formalin-Fixed Paraffin-Embedded (FFPE) pathology samples

PATH-01. ACCURATE AND RAPID PAEDIATRIC BRAIN TUMOR CLASSIFICATION (PBT) BY METHYLATION PROFILING USING NOVEL NATIVE REAL TIME OXFORD NANOPORE TECHNOLOGY SEQUENCING TECHNOLOGY